Tibra Equities Europe’s Pediatrix Medical MD Stock Holding History

Tibra Equities Europe’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,400	Closed	-$218K	–	211
2020 Q3	$218K	Buy	+13,400	New	+$249K	0.05%	155
2019 Q2	–	Sell	-27,400	Closed	-$744K	–	369
2019 Q1	$744K	Buy	27,400 +16,000	+140%	+$536K	0.07%	210
2018 Q4	$376K	Buy	+11,400	New	+$458K	0.06%	143

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Tibra Equities Europe's MD Position: Q4 2020 in Review

Tibra Equities Europe sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 13,400 shares — an estimated $218K sold.

Tibra Equities Europe first reported a position in MD in Q4 2018 and held it in 3 quarters. The position peaked at $744K in Q1 2019. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

Tibra Equities Europe reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
Tibra Equities Europe sold 13,400 Pediatrix Medical shares in Q4 2020, an estimated $218K.
Tibra Equities Europe first reported a position in Pediatrix Medical in Q4 2018 and held it in 3 quarters.
Tibra Equities Europe's Pediatrix Medical position peaked at $744K in Q1 2019.
201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Tibra Equities Europe's 13F filing for Q4 2020, filed 12 Feb 2021.